Pharmacological management of nasal polyposis (Q36201583)

12 August 2017

1 reference

title

Pharmacological management of nasal polyposis (English)

1 reference

12 August 2017

1 reference

1

Claus Bachert

1 reference

12 August 2017

Jean-Baptiste Watelet

series ordinal

2

1 reference

12 August 2017

Philippe Gevaert

series ordinal

3

1 reference

12 August 2017

Paul Van Cauwenberge

series ordinal

4

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

65

1 reference

12 August 2017

11

1 reference

12 August 2017

1537-1552

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565110-00006

12 August 2017

0 references

cites work

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

1 reference

12 December 2020

[Incidence and detection of fungi and eosinophilic granulocytes in chronic rhinosinusitis]

1 reference

12 December 2020

Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.

1 reference

12 December 2020

The diagnosis and incidence of allergic fungal sinusitis

1 reference

12 December 2020

Nasal polyps: effects of seasonal allergen exposure.

1 reference

12 December 2020

Clinical profile and recurrence of nasal polyps

1 reference

12 December 2020

Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration

1 reference

12 December 2020

Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps

1 reference

12 December 2020

Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation

1 reference

12 December 2020

Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation

1 reference

12 December 2020

Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis

1 reference

12 December 2020

Cytokine gene expression in nasal polyps

1 reference

12 December 2020

The role of cytokines in infectious sinusitis and nasal polyposis

1 reference

12 December 2020

Interleukin-5 and eosinophils as therapeutic targets for asthma

1 reference

12 December 2020

Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps

1 reference

12 December 2020

Nasal polyps and their relation to polyps/hypertrophic polypoid mucosa in the paranasal sinuses: a macro-, endo-, and microscopic study of autopsy materials

1 reference

12 December 2020

Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness--a model for non-allergic asthma.

1 reference

12 December 2020

Results of oral steroid treatment in nasal polyposis

1 reference

12 December 2020

The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients

1 reference

12 December 2020

Comparison of effects of anti-IL-3, IL-5 and GM-CSF treatments on eosinophilopoiesis and airway eosinophilia induced by allergen

1 reference

12 December 2020

Staphylococcus aureus enterotoxins: a key in airway disease?

1 reference

12 December 2020

Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis

1 reference

12 December 2020

An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma

1 reference

12 December 2020

A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis

1 reference

12 December 2020

Inhibition of mediator release from dispersed nasal polyp cells by cyclosporin A

1 reference

12 December 2020

Effect of fluticasone in severe polyposis

1 reference

12 December 2020

Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis

1 reference

12 December 2020

Efficacy of soluble IL-4 receptor for the treatment of adults with asthma

1 reference

12 December 2020

Immunological and clinical changes in allergic asthmatics following treatment with omalizumab

1 reference

12 December 2020

Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease

1 reference

12 December 2020

The effect of cetirizine on symptoms and signs of nasal polyposis

1 reference

12 December 2020

Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies

1 reference

12 December 2020

Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis

1 reference

12 December 2020

Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.

1 reference

12 December 2020

The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis

1 reference

12 December 2020

Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide

1 reference

12 December 2020

Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia

1 reference

12 December 2020

Omalizumab improves asthma-related quality of life in patients with severe allergic asthma

1 reference

12 December 2020

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

1 reference

12 December 2020

A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness

1 reference

12 December 2020

Gene regulation by steroid hormones

1 reference

12 December 2020

Epidemiology of nasal polyps

1 reference

12 December 2020

Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis

1 reference

12 December 2020

Acute effects of antileukotrienes on sinonasal polyposis and sinusitis

1 reference

12 December 2020

GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone

1 reference

12 December 2020

CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation

1 reference

12 December 2020

Increased expression of matrix metalloproteinase-9 in nasal polyps

1 reference

12 December 2020

Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults

1 reference

12 December 2020

Efficacy of inhalation form of furosemide to prevent postsurgical relapses of rhinosinusal polyposis

1 reference

12 December 2020

Glucocorticoid receptor localization in normal and asthmatic lung

1 reference

12 December 2020

Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression

1 reference

12 December 2020

Nasal polyposis, eosinophil dominated inflammation, and allergy

1 reference

12 December 2020

Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators

1 reference

12 December 2020

The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis

1 reference

12 December 2020

Cyclosporin as an oral corticosteroid sparing agent in stable asthma

1 reference

12 December 2020

A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis

1 reference

12 December 2020

Inhibition of mediator and cytokine release from dispersed nasal polyp cells by mizolastine

1 reference

12 December 2020

The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy

1 reference

12 December 2020

1 reference

12 December 2020

Molecular mechanisms of anti-inflammatory action of glucocorticoids

1 reference

12 December 2020

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study

1 reference

12 December 2020

Etiology of nasal polyps associated with aspirin-sensitive asthma

1 reference

12 December 2020

Autocrine regulation of eotaxin in normal human bronchial epithelial cells

1 reference

12 December 2020

Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge

1 reference

12 December 2020

Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes

1 reference

12 December 2020

Aspirin-induced asthma: advances in pathogenesis and management

1 reference

12 December 2020

Inflammatory Cytokine Expression on Nasal Polyps Developed in Allergic and Infectious Rhinitis

1 reference

12 December 2020

Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage

1 reference

12 December 2020

Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells.

1 reference

12 December 2020

A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts

1 reference

12 December 2020

[Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome]

1 reference

12 December 2020

Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent

1 reference

12 December 2020

Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps

1 reference

12 December 2020

Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment

1 reference

12 December 2020

Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens

1 reference

12 December 2020

Fireside conference 2. Pathogenesis of nasal polyps

1 reference

12 December 2020

Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells

1 reference

12 December 2020

Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment

1 reference

12 December 2020

Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis

1 reference

12 December 2020

Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis

1 reference

12 December 2020

Intranasal beclomethasone in severe rhinosinusitis and nasal polyps

1 reference

12 December 2020

Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine

1 reference

12 December 2020

Nasal polyposis: clinical course during 20 years

1 reference

12 December 2020

The neutralization of interleukin-5 as a therapeutic concept in allergic inflammation.

1 reference

12 December 2020

Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.

1 reference

12 December 2020

Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day

1 reference

12 December 2020

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

1 reference

12 December 2020

T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines.

1 reference

12 December 2020

Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis.

1 reference

12 December 2020

Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment

1 reference

12 December 2020

Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps.

1 reference

12 December 2020

Overview of allergic mechanisms. Ebastine has more than an antihistamine effect

1 reference

12 December 2020

Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis.

1 reference

12 December 2020

Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis.

1 reference

12 December 2020

Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps

1 reference

12 December 2020

Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells

1 reference

12 December 2020

Airway epithelial cells promote transmigration of eosinophils in a new three-dimensional chemotaxis model.

1 reference

12 December 2020

Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps

1 reference

12 December 2020

Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alph

1 reference

12 December 2020

Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis.

1 reference

12 December 2020

A new class of cyclosporin analogues for the treatment of asthma

1 reference

12 December 2020

Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia

1 reference

12 December 2020

Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells

1 reference

12 December 2020

Nasal polyposis: from cytokines to growth.

1 reference

12 December 2020

Aspirin desensitization in patients with AERD

1 reference

12 December 2020

Total and specific IgE in nasal polyps is related to local eosinophilic inflammation

1 reference

12 December 2020

Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3

1 reference

12 December 2020

Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells

1 reference

12 December 2020

Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis

1 reference

12 December 2020

Topical corticosteroids in nasal polyposis

1 reference

12 December 2020

Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils

1 reference

12 December 2020

Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial)

1 reference

12 December 2020

Arachidonic Acid Metabolites in Human Nasal Polyps

1 reference

12 December 2020

Inhibition of the IL-4/IL-13 receptor system prevents allergic sensitization without affecting established allergy in a mouse model for allergic asthma

1 reference

12 December 2020

Omalizumab and the immune system: an overview of preclinical and clinical data.

1 reference

12 December 2020

[Longitudinal study on nasal polyposis: etiopathogenetic, clinical and therapeutic aspects]

1 reference

12 December 2020

Molecular mechanisms of glucocorticoid action and resistance

1 reference

12 December 2020

Effect of prednisolone on cytokine synthesis in nasal polyps

1 reference

12 December 2020

Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease.

1 reference

12 December 2020

IL-5 synthesis is upregulated in human nasal polyp tissue

1 reference

12 December 2020

Effect of furosemide on prostaglandin synthesis by human nasal and bronchial epithelial cells in culture

1 reference

12 December 2020

Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

1 reference

12 December 2020

Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma

1 reference

12 December 2020

Endoscopically guided cultures in chronic sinusitis

1 reference

12 December 2020

Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis

1 reference

12 December 2020

10.2165/00003495-200565110-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference